Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biochemical markers in prostatic cancer.

M J Schacht, J E Garnett, J T Grayhack

    The Urologic Clinics of North America
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Endobronchial ultrasound-guided transbronchial needle aspiration: performance of biomedical scientists on rapid on-site evaluation and preliminary diagnosis.

    Cytopathology : official journal of the British Society for Clinical Cytology·2016
    Same author

    High fat diet increases the weight of rat ventral prostate.

    The Prostate·2001
    Same author

    Experimental cryptorchidism inhibited growth of the rat ventral prostate.

    Journal of andrology·2000
    Same author

    Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates.

    The Prostate·1999
    Same author

    Differential growth rates in stromal cultures of human prostate derived from patients of varying ages.

    The Prostate·1999
    Same author

    Total protein and acid phosphatase concentrations in prostatic fluid from patients with BPH compared to carcinoma.

    International urology and nephrology·1998

    No single biochemical marker for prostate cancer has been found. However, various serum, urine, and prostatic fluid substances aid in disease staging and monitoring treatment response.

    Area of Science:

    • Oncology
    • Biochemistry
    • Urology

    Background:

    • Prostate cancer diagnosis and management rely on identifying reliable biomarkers.
    • Current diagnostic methods require refinement for improved patient outcomes.

    Purpose of the Study:

    • To review the current status of biochemical markers for prostate cancer.
    • To evaluate the utility of various substances in disease staging and therapy monitoring.

    Main Methods:

    • Literature review of studies evaluating biochemical markers in prostate cancer patients.
    • Analysis of substances found in serum, urine, and prostatic fluid.
    • Assessment of marker performance in disease staging and treatment response.

    Main Results:

    Related Experiment Videos

    • No single, unique biochemical marker for prostate cancer has been identified.
    • Several enzymes and specific proteins show potential utility.
    • These markers are valuable for staging disease and monitoring therapeutic effectiveness.

    Conclusions:

    • Biochemical markers play a crucial role in prostate cancer management.
    • Continued research is needed to identify more specific and sensitive biomarkers.
    • Current markers are best utilized in conjunction with other clinical data.